GB9323199D0 - Leukaemia treatment - Google Patents

Leukaemia treatment

Info

Publication number
GB9323199D0
GB9323199D0 GB939323199A GB9323199A GB9323199D0 GB 9323199 D0 GB9323199 D0 GB 9323199D0 GB 939323199 A GB939323199 A GB 939323199A GB 9323199 A GB9323199 A GB 9323199A GB 9323199 D0 GB9323199 D0 GB 9323199D0
Authority
GB
United Kingdom
Prior art keywords
leukaemia
treatment
leukaemia treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939323199A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Falkenberg J H F
Original Assignee
Falkenberg J H F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Falkenberg J H F filed Critical Falkenberg J H F
Priority to GB939323199A priority Critical patent/GB9323199D0/en
Publication of GB9323199D0 publication Critical patent/GB9323199D0/en
Priority to PCT/GB1994/002470 priority patent/WO1995013093A1/fr
Priority to AU81132/94A priority patent/AU8113294A/en
Pending legal-status Critical Current

Links

GB939323199A 1993-11-10 1993-11-10 Leukaemia treatment Pending GB9323199D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB939323199A GB9323199D0 (en) 1993-11-10 1993-11-10 Leukaemia treatment
PCT/GB1994/002470 WO1995013093A1 (fr) 1993-11-10 1994-11-10 Traitement d'un patient avant une transplantation
AU81132/94A AU8113294A (en) 1993-11-10 1994-11-10 Treatment of a patient prior to transplantation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939323199A GB9323199D0 (en) 1993-11-10 1993-11-10 Leukaemia treatment

Publications (1)

Publication Number Publication Date
GB9323199D0 true GB9323199D0 (en) 1994-01-05

Family

ID=10744958

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939323199A Pending GB9323199D0 (en) 1993-11-10 1993-11-10 Leukaemia treatment

Country Status (3)

Country Link
AU (1) AU8113294A (fr)
GB (1) GB9323199D0 (fr)
WO (1) WO1995013093A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3255061T (pt) 2006-11-03 2021-07-26 Univ Leland Stanford Junior Imunodepleção seletiva de nicho de células estaminais endógenas para enxerto
SG187840A1 (en) * 2010-08-18 2013-03-28 Theresa Deisher Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
US10426740B1 (en) 2010-08-18 2019-10-01 Avm Biotechnology, Llc Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
KR20180026370A (ko) 2015-04-06 2018-03-12 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 비-골수제거적 컨디셔닝을 위한 조성물 및 방법
WO2017219025A1 (fr) 2016-06-17 2017-12-21 Magenta Therapeutics, Inc. Compositions et méthodes de déplétion de cellules
SG10202100726XA (en) 2016-06-17 2021-02-25 Magenta Therapeutics Inc Compositions and methods for the depletion of cd117+cells
IL268058B2 (en) 2017-01-20 2023-09-01 Magenta Therapeutics Inc Compositions and methods for depleting cd137 plus cells
MX2019011679A (es) 2017-04-01 2019-11-01 Avm Biotechnology Llc Reemplazo de un pre-acondicionamiento citotoxico antes de una inmunoterapia celular.
EP3488851A1 (fr) 2018-10-03 2019-05-29 AVM Biotechnology, LLC Thérapies immunoablatives
GB202015226D0 (en) 2020-09-25 2020-11-11 Adc Therapeutics S A Pyrrol obenzodiazepine-antibody conugates and uses thereof
GB202015235D0 (en) 2020-09-25 2020-11-11 Ucl Business Plc Anti-CD45 antibodies and related therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710457A (en) * 1983-06-29 1987-12-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibody for human hematopoietic glycoproteins and method
US5273738A (en) * 1990-03-03 1993-12-28 Fred Hutchinson Cancer Research Center Radiation delivery to lymphoid and marrow tissues
EP0610257A1 (fr) * 1991-10-18 1994-08-17 Cantab Pharmaceuticals Research Limited Perfusion in vitro de greffes de reins avec des anticorps

Also Published As

Publication number Publication date
WO1995013093A1 (fr) 1995-05-18
AU8113294A (en) 1995-05-29

Similar Documents

Publication Publication Date Title
GB9303210D0 (en) Cancer treatment
GB9323199D0 (en) Leukaemia treatment
GB9203039D0 (en) Treatment
ZA942809B (en) Treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
GB2284706B (en) Treatment apparatus
GB2280096B (en) Belt
GB2274395B (en) Massager
GB9317634D0 (en) Antificial limb component
GB9309542D0 (en) Herbicidal treatment
GB2274824B (en) Non-refilling devices
GB9310836D0 (en) Treatment
ZA948336B (en) Treatment
GB9314491D0 (en) Novel treatment
GB9301958D0 (en) Treatment device
GB9310610D0 (en) Gastrointestinal treatment
KR960006881Y1 (en) Hand-ring for acupuncture
GB9315150D0 (en) Rail treatment
GB2274637B (en) Non-refilling devices
GB2274639B (en) Non-refilling devices
GB2274638B (en) Non-refilling devices
GB9321591D0 (en) Novel compounds and treatment
GB9321592D0 (en) Novel compounds and treatment
GB9302289D0 (en) Novel compounds and treatment
GB9302314D0 (en) Novel compounds and treatment